China can offer access to large numbers of patients, including treatment naive patietns, through more than 250 major hospitals which have been approved do clinical research by the SFDA. Along with this, there are over 300 local clinical research organisations in the country, some of whom could be ideal partners for your studies.

China is well on the way to becoming a significant pharmaceutical and medical device market. Conducting a portion of your clinical research there could be an advantage in helping you enter this market.

Through our partner network of CRO's, Zero Paradox is able to offer a wide range of clinical services including:

• Pre-clinical research
• Phase II - III trials
• Bioequivalance studies
• Management of clinical supplies

Clinical studies may be conducted through our partners for:

• Wide range of therapeutic conditions
• Medical devices
• Consumer healthcare products